Lillicrap D - Search Results

1

The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays.

Lassalle F, Jourdy Y, Jouan L, Swystun L, Gauthier J, Zawadzki C, Goudemand J, Susen S, Rivard GE, Lillicrap D. Lassalle F, et al. Among authors: lillicrap d. Haemophilia. 2020 Nov;26(6):1056-1063. doi: 10.1111/hae.14179. Epub 2020 Oct 23. Haemophilia. 2020. PMID: 33094873

2

Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease.

Lillicrap D, Murray EW, Benford K, Blanchette VS, Rivard GE, Wensley R, Giles AR. Lillicrap D, et al. Br J Haematol. 1991 Dec;79(4):612-7. doi: 10.1111/j.1365-2141.1991.tb08089.x. Br J Haematol. 1991. PMID: 1772783

3

Carrier detection of haemophilia A using DNA markers in families with an isolated affected male.

Grover H, Phillips MA, Lillicrap DP, Giles AR, Garvey MB, Teitel J, Rivard G, Blanchette V, White BN, Holden JJ. Grover H, et al. Among authors: lillicrap dp. Clin Genet. 1987 Jul;32(1):10-9. doi: 10.1111/j.1399-0004.1987.tb03316.x. Clin Genet. 1987. PMID: 2887317

4

The molecular basis of haemophilia B.

Lillicrap D. Lillicrap D. Haemophilia. 1998 Jul;4(4):350-7. doi: 10.1046/j.1365-2516.1998.440350.x. Haemophilia. 1998. PMID: 9873754 Review.

5

Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?

Rivard GE, Lillicrap D, Poon MC, Demers C, Lépine M, St-Louis J, Warner M. Rivard GE, et al. Among authors: lillicrap d. Haemophilia. 2005 Jul;11(4):335-9. doi: 10.1111/j.1365-2516.2005.01088.x. Haemophilia. 2005. PMID: 16011584

6

Cellular and genetic therapies for haemophilia.

Lillicrap D, VandenDriessche T, High K. Lillicrap D, et al. Haemophilia. 2006 Jul;12 Suppl 3:36-41. doi: 10.1111/j.1365-2516.2006.01259.x. Haemophilia. 2006. PMID: 16683995 Review.

7

Laboratory issues in bleeding disorders.

Lillicrap D, Nair SC, Srivastava A, Rodeghiero F, Pabinger I, Federici AB. Lillicrap D, et al. Haemophilia. 2006 Jul;12 Suppl 3:68-75. doi: 10.1111/j.1365-2516.2006.01279.x. Haemophilia. 2006. PMID: 16683999 Review.

8

Different clinical phenotype in triplets with haemophilia A.

Barnes C, Blanchette V, Lillicrap D, Mann K, Stain AM, Leggo J, Hilliard P, Carcao M. Barnes C, et al. Among authors: lillicrap d. Haemophilia. 2007 Mar;13(2):202-5. doi: 10.1111/j.1365-2516.2006.01396.x. Haemophilia. 2007. PMID: 17286775

9

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.

Rubinger M, Lillicrap D, Rivard GE, Teitel J, Carcao M, Hensman C, Walker I; Association of Hemophilia Clinic Directors of Canada. Rubinger M, et al. Among authors: lillicrap d. Haemophilia. 2008 Mar;14(2):281-6. doi: 10.1111/j.1365-2516.2007.01634.x. Epub 2008 Jan 8. Haemophilia. 2008. PMID: 18194308

10

von Willebrand disease update: diagnostic and treatment dilemmas.

Bolton-Maggs PH, Lillicrap D, Goudemand J, Berntorp E. Bolton-Maggs PH, et al. Among authors: lillicrap d. Haemophilia. 2008 Jul;14 Suppl 3:56-61. doi: 10.1111/j.1365-2516.2008.01713.x. Haemophilia. 2008. PMID: 18510523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page